3ZUQ
Crystal structure of an engineered botulinum neurotoxin type B - derivative, LC-B-GS-Hn-B
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I03 |
Synchrotron site | Diamond |
Beamline | I03 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2010-08-09 |
Detector | ADSC CCD |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 89.370, 103.790, 114.950 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 77.030 - 2.700 |
R-factor | 0.24942 |
Rwork | 0.248 |
R-free | 0.28120 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2xhl |
RMSD bond length | 0.006 |
RMSD bond angle | 0.844 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | REFMAC (5.5.0109) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 58.400 | 2.850 |
High resolution limit [Å] | 2.700 | 2.700 |
Rmerge | 0.130 | 0.490 |
Number of reflections | 28039 | |
<I/σ(I)> | 8.5 | 3.3 |
Completeness [%] | 93.3 | 100 |
Redundancy | 5.2 | 5.4 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 8 | 0.1M TRIS ACETATE PH8.0, 0.2M MGCL, 20% PEG8000 |